Stockscreener 앱 받기
42.91
0.52%
0.22
시장 영업 전:
42.57
-0.34
-0.79%
Tempus Ai Inc 주식(TEM)의 최신 뉴스
Eagle Health Investments LP Takes Position in Tempus AI, Inc. $TEM - MarketBeat
TEM|Tempus AI Inc|Price:42.930|Chg%:+0.240 - TradingKey
Artificial Intelligence Stocks To Keep An Eye OnJuly 27th - MarketBeat
Tempus AI Stock (TEM) Opinions on Personalis Acquisition and Analyst Upgrades - Quiver Quantitative
Tempus AI to Acquire Personalis in $1.5 Billion Deal, Deepening Its Foothold in Cancer Monitoring - Oncodaily
Tempus AI, Inc. (TEM) Stock Analysis: Exploring the 55.94% Potential Upside and Analyst Ratings - DirectorsTalk Interviews
Tempus AI Inc (TEM) Balance Sheet - TradingKey
AI Stocks: Why Tempus AI (NASDAQ:TEM), Recursion Pharmaceuticals (NASDAQ:RXRX) and Schrodinger (NASDAQ:SDGR) Are in Focus - Kalkine Media
Tempus AI Inc (TEM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Tempus AI Inc (TEM) Income Statement - TradingKey
Alan Tan: Highlighting Ultrasensitive MRD Detection with Tempus AI at KCRS26 - Oncodaily
136,636 Shares in Tempus AI, Inc. $TEM Acquired by Aristotle Atlantic Partners LLC - MarketBeat
Tempus AI (NASDAQ:TEM) Shares Fall 19% as Attention Turns to Merger Collar - TechStock²
Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM), Brainsway (BWAY) and Argenx Se (ARGX) - The Globe and Mail
Tempus AI Inc (TEM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tempus AI Inc (TEM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Tempus AI Inc|Price:42.690|Chg%:-3.320 - TradingKey
Tempus AI (NASDAQ:TEM) Upgraded to Hold at Wall Street Zen - MarketBeat
Tempus AI stock: H.C. Wainwright reiterates Buy on MRD expansion - Investing.com UK
Tempus AI buys Personalis for $1.5B; UCSF Health, Kleiner Perkins and Doerr Capital launch health AI accelerator; Candid Health raises $120M - VatorNews
Tempus AI Stock Before Q2 Earnings Release: To Buy, Hold or Sell? - Yahoo Finance
Tempus to acquire Personalis in $1.5 billion deal to expand MRD capabilities - DOTmed
Tempus AI stock: H.C. Wainwright reiterates Buy on MRD expansion By Investing.com - Investing.com Canada
GC Wealth Management RIA LLC Cuts Position in Tempus AI, Inc. $TEM - MarketBeat
Cathie Wood buys $8.7 million of beaten-down AI stock - thestreet.com
Artificial Intelligence Stocks To Follow NowJuly 23rd - MarketBeat
Tempus AI (TEM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Yahoo! Finance Canada
Tempus AI (TEM) Expected to Announce Earnings on Thursday - MarketBeat
Tempus AI (TEM) Unveils National Rollout of Pharmacogenomics Tes - GuruFocus
Tempus AI Expands Cancer Platform With Launch of ArteraAI Prostate Test For Metastatic Patients - Stocktwits
Tempus makes $1.5B bet to corner cancer-test market - thestreet.com
Tempus AI Makes Billion-Dollar Bet on the Future of Cancer Monitoring - Sahm
What's behind Tempus AI's latest 3.5% stock pullback? - Traders Union
Best Artificial Intelligence Stocks To Follow TodayJuly 22nd - MarketBeat
Why is Tempus AI stock sliding today? By Investing.com - Investing.com Canada
Tempus AI launches pharmacogenomics testing nationwide By Investing.com - Investing.com Nigeria
Tempus AI launches pharmacogenomics testing nationwide - Investing.com
Tempus Launches Test for Therapies With Nearly 30% Severe Toxicities - Stock Titan
Tempus AI to Acquire Cancer Diagnostics Firm Personalis for approximately $1.5 Billion, Targeting MRD Market Leadership - finance.biggo.com
Tempus AI (TEM) On Its Personalis Deal And Whether The Bull Case Is Priced In - Yahoo Finance
Cathie Wood’s Tempus AI Bet Is Bleeding — And the Chart Looks Worse Than Wall Street Thinks - Sahm
Tempus to acquire Personalis, Inc. (PSNL) in cash and stock merger - Stock Titan
Tempus AI: Buy Rating Reaffirmed as Personalis Deal Strengthens MRD Position; $75 Price Target Maintained - TipRanks
Why Is Tempus AI Stock Volatile Tuesday?Personalis (NASDAQ:PSNL), Tempus AI (NASDAQ:TEM) - Benzinga
TEM, PSNL stocks are falling — why Morgan Stanley still likes Tempus AI’s Personalis deal - MSN
Tempus AI buys Personalis for $1.5 billion - grafa.com
Artificial Intelligence Stocks To Add to Your WatchlistJuly 21st - MarketBeat
Tempus AI Buys Personalis for $1.5B to Boost Cancer Monitoring - Medical Device and Diagnostic industry
Tempus AI to Acquire Personalis for $1.5 Billion to Expand Precision Oncology Platform - HLTH
Tempus AI Stock Short Interest Falls to 33.94% - Quiver Quantitative
Tempus AI is acquiring cancer-monitoring firm Personalis in a $1.5 billion stock deal - qz.com
Tempus AI Acquires Personalis: Why Both Stocks Are A Buy Now (NASDAQ:TEM) - Seeking Alpha
Tempus AI acquires cancer-monitoring firm Personalis for $1.5 billion - Yahoo Finance
Tempus AI acquires Personalis in $1.5bn precision oncology-focused deal - Yahoo Finance
Tempus AI snaps up genomics partner Personalis for $1.5 billion - The Pharma Letter
Tempus AI (TEM) to Acquire Personalis in Strategic Move - GuruFocus
Tempus AI (TEM) Is Buying Personalis For $1.5 Billion To Deepen Cancer Monitoring - Yahoo Finance
Tempus AI (TEM) Stock May Be A Bargain Despite Its 22% Slump - Yahoo Finance
Tempus AI, Inc. $TEM Stake Boosted by Amova Asset Management Americas Inc. - MarketBeat
Personalis, Inc. (PSNL) Tempus AI, Inc.M&A CallSlideshow (NASDAQ:PSNL) 2026-07-20 - Seeking Alpha
Tempus AI Stock Near 1-Year Low: Cathie Wood’s ARK Buys More While Offloading Nvidia, Meta, Other Tech Plays - Stocktwits
Jefferies reiterates Tempus AI stock rating on acquisition concerns By Investing.com - Investing.com South Africa
Tempus AI Buys Personalis for $1.5 Billion, and Both Stocks Sink -- Barrons.com - Moomoo
Latham, Cooley Steer $1.5B Tempus Cancer Testing Deal - Law360
Tempus AI (TEM) plans stock-plus-cash merger with Personalis (PSNL) - Stock Titan
Tempus AI and Personalis (NASDAQ: PSNL) detail merger risks and upcoming SEC filings - Stock Titan
Tempus AI Announces Merger Agreement to Acquire Personalis - TipRanks
4.67%
0.76%
자본화:
|
볼륨(24시간):